We are live on
!
Find out more
SSA
South Street Advisors Portfolio holdings
AUM
$769M
1-Year Est. Return
50.16%
This Fund
S&P 500
This Quarter
Est. Return
+26.78%
1 Year Est. Return
+50.16%
3 Year Est. Return
+169.23%
5 Year Est. Return
+236.82%
10 Year Est. Return
+757.25%
AUM
$374M
AUM Growth
+$69.8M
(+23%)
Cap. Flow
-$867K
Cap. Flow
% of AUM
-0.23%
Top 10 Holdings %
Top 10 Hldgs %
47.54%
Holding
60
New
5
Increased
19
Reduced
16
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.4M |
| 2 |
XPO
XPO
|
+$5.79M |
| 3 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$4.68M |
| 4 |
AbbVie
ABBV
|
+$1.8M |
| 5 |
BHP
BHP
|
+$752K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$10.6M |
| 2 |
Warner Bros
WBD
|
+$8.18M |
| 3 |
AGN
Allergan plc
AGN
|
+$4.18M |
| 4 |
PayPal
PYPL
|
+$2.34M |
| 5 |
NVIDIA
NVDA
|
+$2.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.13% |
| 2 | Financials | 18.48% |
| 3 | Industrials | 12.36% |
| 4 | Communication Services | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Boeing
BA
$183B
| $285K | 0.08% |
1,557
| – | – |
|
52
Progressive
PGR
$125B
| $280K | 0.07% |
3,500
| – | – |
|
53
Enterprise Products Partners
EPD
$81.8B
| $277K | 0.07% |
15,240
| – | – |
|
54
SolarEdge
SEDG
$2.01B
| $265K | 0.07% |
+1,910
| New | +$234K |
|
55
Intel
INTC
$497B
| $256K | 0.07% |
4,282
-1,600
| -27% | -$95.7K |
|
56
Novartis
NVS
$297B
| $227K | 0.06% |
2,600
| – | – |
|
57
ExxonMobil
XOM
$632B
| $221K | 0.06% |
+4,950
| New | +$222K |
|
|
58
Boston Scientific
BSX
$72.4B
| – | – |
-324,323
| Closed | -$10.6M |
|
|
59
Warner Bros
WBD
$66.8B
| – | – |
-420,640
| Closed | -$8.18M |
|
|
AGN
60
DELISTED
Allergan plc
AGN
| – | – |
-23,598
| Closed | -$4.18M |
|
Similar funds
WI
CCA
PGA
FA
CCIP
SC
PA
TI
South Street Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, South Street Advisors held 60 positions worth $374M, up 23% from $304M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
South Street Advisors's Q2 2020 filing shows 5 new, 19 increased, 16 reduced and 3 closed positions. Its largest new stake was Bristol-Myers Squibb: 207,995 shares worth $12.2M. The largest sale was Boston Scientific, an estimated $10.6M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.
- South Street Advisors's largest Q2 2020 buy was Bristol-Myers Squibb: 207,995 shares worth $12.2M.
- South Street Advisors added most to MGM Growth Properties LLC Class A common shares representing limited liability company interests in Q2 2020, an estimated $4.68M increase.
- South Street Advisors's biggest Q2 2020 reduction was PayPal, cutting an estimated $2.34M.
- South Street Advisors fully exited Boston Scientific in Q2 2020, selling an estimated $10.6M.
- South Street Advisors's ten largest holdings make up 48% of its $374M portfolio in Q2 2020.
- South Street Advisors opened 5 new positions and closed 3 in Q2 2020.
- South Street Advisors's portfolio value rose 23% quarter-over-quarter to $374M.
Based on South Street Advisors's 13F filing for Q2 2020, filed 4 Aug 2020.